Valaciclovir

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Phase III Study of ASP2151 in Herpes Zoster Patients

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

To Rescue Cognition With Valaciclovir

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Valaciclovir to Prevent Transmission of Herpes Simplex Virus